Saroglitazar magnesium
Sponsors
Zydus Therapeutics Inc.
Conditions
HealthyPrimary Biliary Cholangitis (PBC)Renal Impairment
Phase 1
Study to Evaluate Absorption, Metabolism and Excretion of Single-dose [14C]-Saroglitazar in Healthy Male Subjects
CompletedNCT04112446
Start: 2019-09-20End: 2019-10-29Updated: 2019-11-13
A Pharmacokinetic Study of Saroglitazar Magnesium in Subjects with Severe Renal Impairment and Normal Renal Function
CompletedNCT04446507
Start: 2020-07-27End: 2024-05-28Updated: 2024-09-20